Tuesday, 06 October 2026 01:00 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / October 6, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ClearPoint Neuro, Inc. ("ClearPoint" or "the Company") (NASDAQ:CLPT). Investors who purchased ClearPoint securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/clearpoint-neuro-inc-clpt-class_action_lawsuit.
ClearPoint Investigation Details
On September 29, 2026, uniQure N.V. ("UniQure"), ClearPoint's development partner, issued a press release "announc[ing] additional data from the ongoing Phase I/II studies of ifezuntirgene inilparvovec for the treatment of Huntington's disease." The press release disclosed that the treatment did not achieve statistical significance on a primary clinical measure at 48 months. Following this news, ClearPoint's stock price fell $3.54 per share, or 23.12%, to close at $11.77 per share on September 29, 2026.
What's Next for ClearPoint Investors?
If you are aware of any facts relating to this investigation or purchased ClearPoint securities, you can assist this investigation by visiting the firm's site: bgandg.com/cases/clearpoint-neuro-inc-clpt-class_action_lawsuit. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to ClearPoint Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ClearPoint Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE: Bronstein, Gewirtz & Grossman, LLC